Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab
Technology
E-136-2018
Patent ID
E-136-2018-1-AT-12
Country
AT
Application Type
EP
Patent Status
Issued
Patent Number
Publication Number
3417294
Application Number
17753704.0
IC
NCI
Date Filed
Date Issued
Patent PDF